Regulus Therapeutics Inc. (RGLS) said Tuesday that it has named Stelios Papadopoulos Chairman of its Board of Directors, effective immediately.
Dr. Papadopoulos assumes the role of Chairman of the Board from John Maraganore, who will remain a member of the board.
Dr. Papadopoulos, who has been a member of the Regulus board since 2008, has more than 30 years of experience in the biotechnology and pharmaceutical industries as an investment banker, board member, company founder and investor. He is a Board member of several companies including Biogen Idec, Inc. and Exelixis, Inc., where he is Chairman.
For comments and feedback: editorial@rttnews.com